Mao-bing Chen

Jiangsu University — China

Medicine · Health Sciences

5h-index122citations13works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Diabetes Treatment and Management(5), Hepatitis C virus research(4), Hepatitis B Virus Studies(4), Diabetes Management and Research(4), Liver Disease Diagnosis and Treatment(3)

Publications13 total

Smoking behaviors, physical activities, pulmonary diseases and COVID-19 severity: A Mendelian randomization study
Medicine·2024Open Access
Efficacy of probiotic adjuvant therapy for irritable bowel syndrome in children: A systematic review and meta-analysis
PLoS ONE·2021· 19 citedOpen Access
Effect of SGLT inhibitors on weight and lipid metabolism at 24 weeks of treatment in patients with diabetes mellitus
Medicine·2021· 22 citedOpen Access
Effect of sodium-dependent glucose transporter inhibitors on glycated hemoglobin A1c after 24 weeks in patients with diabetes mellitus
Medicine·2021· 5 citedOpen Access
Efficacy and safety of sotagliflozin adjuvant therapy for type 1 diabetes mellitus
Medicine·2020· 15 citedOpen Access
The efficacy of masks for influenza-like illness in the community
Medicine·2020· 5 citedOpen Access
Comparative efficacy of the front-line anti-HBV drugs in nucleos(t)ide analogue-naive chronic hepatitis B
Medicine·2020· 1 citedOpen Access
Comparative efficacy of the front-line anti-HBV drugs in nucleos(t)ide analogue-naive chronic hepatitis B, A protocol for systematic review and network meta-analysis
2020· 1 citedOpen Access
Comparative efficacy of tenofovir and entecavir in nucleos(t)ide analogue-naive chronic hepatitis B: A systematic review and meta-analysis
PLoS ONE·2019· 41 citedOpen Access
A comparison of sotagliflozin therapy for diabetes mellitus between week 24 with week 52
Medicine·2019· 1 citedOpen Access
Effectiveness and safety of hypotensive resuscitation in traumatic hemorrhagic shock
Medicine·2019· 8 citedOpen Access
Effectiveness of tenofovir and entecavir in nucleos(t)ide analogue-naive chronic hepatitis B
Medicine·2019· 2 citedOpen Access
Effectiveness and safety of sotagliflozin adjuvant therapy for type 1 diabetes mellitus
Medicine·2019· 2 citedOpen Access

Frequent Co-authors

Qi-han Zheng(12), Xuwen Zheng(8), Hua Wang(6), Wei-Yan Cui(6), Hua-Lan Xu(5), Yunlong Ding(4), Jin-nuo Fan(2), Hua Wang(2), Wenming Shen(2), Ruijun Xu(2), Mao-Xing Yue(2), Jiali Niu(1), Lili Zou(1), Hua Wang(1), Hua Wang(1), Nie Zhang(1), Zhiqun Gu(1), Yang Liu(1), Hua Wang(1), Hualan Xu(1)